5 million Covishield doses meant for export to UK to be used in India | Latest News India - Hindustan Times
close_game
close_game

5 million Covishield doses meant for export to UK to be used in India

PTI | , New Delhi
May 07, 2021 11:03 PM IST

The Serum Institute had on March 23 sought permission from the ministry to supply 50 lakh doses of Covishield to the UK, citing an agreement with AstraZeneca in this regard, while assuring India that its own anti-coronavirus vaccination programme will not be disturbed due to this supply.

Fifty lakh doses of ‘Covishield’ vaccine earmarked by the Serum Institute for export to the United Kingdom have now been made available for the inoculation of 18-44 age group in 21 states/UTs in India, amid a surge in COVID-19 cases, official sources said.

A health worker inoculates a woman with a dose of Covishield Covid-19 coronavirus vaccine at a vaccination centre in Mumbai. (AFP)
A health worker inoculates a woman with a dose of Covishield Covid-19 coronavirus vaccine at a vaccination centre in Mumbai. (AFP)

The Centre's decision to allocate these doses to 21 states and Union territories (UTs) came after Prakash Kumar Singh, director, Government and Regulatory Affairs at Pune-based Serum Institute of India, recently wrote to the Union health ministry seeking permission for the same.

Hindustan Times - your fastest source for breaking news! Read now.

The Serum Institute had on March 23 sought permission from the ministry to supply 50 lakh doses of Covishield to the UK, citing an agreement with AstraZeneca in this regard, while assuring India that its own anti-coronavirus vaccination programme will not be disturbed due to this supply.

"The stock of 50 lakh doses of Covishield vaccine is now available for inoculation of 18-44 age group people in 21 states and UTs," an official source said.

The ministry has asked the states to contact the company and initiate procurement activity promptly.

While some states have been allocated 3,50,000 doses each, others got 1,00,000 doses each and two others have been assigned 50,000 doses each based on the COVID-19 caseload, official sources said.

The jabs are labelled as ‘COVID-19 Vaccine AstraZeneca’ injections and not ‘Covishield’.

Developed by Oxford University and Swedish-British pharma major AstraZeneca, Covishield is being manufactured by the Serum Institute of India (SII).

India saw a record 4,14,188 new coronavirus infections in a day, pushing the total tally of COVID-19 cases to 2,14,91,598, while the death toll increased to 2,34,083 with 3,915 fatalities being reported in a span of 24 hours, according to the ministry data updated on Friday morning.

The countrywide vaccination drive was rolled out on January 16 with healthcare workers (HCWs) getting inoculated and the vaccination of frontline workers (FLWs) started from February 2.

The next phase of the COVID-19 vaccination commenced from March 1 for those over 60 years of age and for people aged 45 and above with specified co-morbid conditions.

India launched vaccination for all people aged more than 45 years from April 1.

Implementation of the Liberalised and Accelerated Phase 3 Strategy of COVID-19 Vaccination to inoculate those in the age group of 18-44 years started from May 1.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On